Rising statin use and effect on ischemic stroke outcome

Sung Sug Yoon, James Dambrosia, Julio Chalela, Mustapha Ezzeddine, Steven Warach, Joseph Haymore, Lisa Davis, Alison E. Baird

Research output: Contribution to journalArticle

64 Citations (Scopus)

Abstract

Background: Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) have neuroprotective effects in experimental stroke models and are commonly prescribed in clinical practice. The aim of this study was to determine if patients taking statins before hospital admission for stroke had an improved clinical outcome. Methods: This was an observational study of 436 patients admitted to the National Institutes of Health Suburban Hospital Stroke Program between July 2000 and December 2002. Self-reported risk factors for stroke were obtained on admission. Stroke severity was determined by the admission National Institutes of Health Stroke Scale score. Good outcome was defined as a Rankin score < 2 at discharge. Statistical analyses used univariate and multivariate logistic regression models. Results: There were 436 patients with a final diagnosis of ischemic stroke; statin data were available for 433 of them. A total of 95/433 (22%) of patients were taking a statin when they were admitted, rising from 16% in 2000 to 26% in 2002. Fifty-one percent of patients taking statins had a good outcome compared to 38% of patients not taking statins (p = 0.03). After adjustment for confounding factors, statin pretreatment was associated with a 2.9 odds (95% CI: 1.2-6.7) of a good outcome at the time of hospital discharge. Conclusions: The proportion of patients taking statins when they are admitted with stroke is rising rapidly. Statin pretreatment was significantly associated with an improved functional outcome at discharge. This finding could support the early initiation of statin therapy after stroke.

Original languageEnglish (US)
Article number4
JournalBMC Medicine
Volume2
DOIs
StatePublished - Mar 23 2004

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Stroke
National Institutes of Health (U.S.)
Logistic Models
Neuroprotective Agents
Observational Studies
Oxidoreductases
Theoretical Models

ASJC Scopus subject areas

  • Medicine(all)
  • Public Health, Environmental and Occupational Health

Cite this

Yoon, S. S., Dambrosia, J., Chalela, J., Ezzeddine, M., Warach, S., Haymore, J., ... Baird, A. E. (2004). Rising statin use and effect on ischemic stroke outcome. BMC Medicine, 2, [4]. https://doi.org/10.1186/1741-7015-2-4

Rising statin use and effect on ischemic stroke outcome. / Yoon, Sung Sug; Dambrosia, James; Chalela, Julio; Ezzeddine, Mustapha; Warach, Steven; Haymore, Joseph; Davis, Lisa; Baird, Alison E.

In: BMC Medicine, Vol. 2, 4, 23.03.2004.

Research output: Contribution to journalArticle

Yoon, SS, Dambrosia, J, Chalela, J, Ezzeddine, M, Warach, S, Haymore, J, Davis, L & Baird, AE 2004, 'Rising statin use and effect on ischemic stroke outcome', BMC Medicine, vol. 2, 4. https://doi.org/10.1186/1741-7015-2-4
Yoon SS, Dambrosia J, Chalela J, Ezzeddine M, Warach S, Haymore J et al. Rising statin use and effect on ischemic stroke outcome. BMC Medicine. 2004 Mar 23;2. 4. https://doi.org/10.1186/1741-7015-2-4
Yoon, Sung Sug ; Dambrosia, James ; Chalela, Julio ; Ezzeddine, Mustapha ; Warach, Steven ; Haymore, Joseph ; Davis, Lisa ; Baird, Alison E. / Rising statin use and effect on ischemic stroke outcome. In: BMC Medicine. 2004 ; Vol. 2.
@article{2a52b52999294fe185b4d4a1227bcf06,
title = "Rising statin use and effect on ischemic stroke outcome",
abstract = "Background: Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) have neuroprotective effects in experimental stroke models and are commonly prescribed in clinical practice. The aim of this study was to determine if patients taking statins before hospital admission for stroke had an improved clinical outcome. Methods: This was an observational study of 436 patients admitted to the National Institutes of Health Suburban Hospital Stroke Program between July 2000 and December 2002. Self-reported risk factors for stroke were obtained on admission. Stroke severity was determined by the admission National Institutes of Health Stroke Scale score. Good outcome was defined as a Rankin score < 2 at discharge. Statistical analyses used univariate and multivariate logistic regression models. Results: There were 436 patients with a final diagnosis of ischemic stroke; statin data were available for 433 of them. A total of 95/433 (22{\%}) of patients were taking a statin when they were admitted, rising from 16{\%} in 2000 to 26{\%} in 2002. Fifty-one percent of patients taking statins had a good outcome compared to 38{\%} of patients not taking statins (p = 0.03). After adjustment for confounding factors, statin pretreatment was associated with a 2.9 odds (95{\%} CI: 1.2-6.7) of a good outcome at the time of hospital discharge. Conclusions: The proportion of patients taking statins when they are admitted with stroke is rising rapidly. Statin pretreatment was significantly associated with an improved functional outcome at discharge. This finding could support the early initiation of statin therapy after stroke.",
author = "Yoon, {Sung Sug} and James Dambrosia and Julio Chalela and Mustapha Ezzeddine and Steven Warach and Joseph Haymore and Lisa Davis and Baird, {Alison E.}",
year = "2004",
month = "3",
day = "23",
doi = "10.1186/1741-7015-2-4",
language = "English (US)",
volume = "2",
journal = "BMC Medicine",
issn = "1741-7015",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Rising statin use and effect on ischemic stroke outcome

AU - Yoon, Sung Sug

AU - Dambrosia, James

AU - Chalela, Julio

AU - Ezzeddine, Mustapha

AU - Warach, Steven

AU - Haymore, Joseph

AU - Davis, Lisa

AU - Baird, Alison E.

PY - 2004/3/23

Y1 - 2004/3/23

N2 - Background: Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) have neuroprotective effects in experimental stroke models and are commonly prescribed in clinical practice. The aim of this study was to determine if patients taking statins before hospital admission for stroke had an improved clinical outcome. Methods: This was an observational study of 436 patients admitted to the National Institutes of Health Suburban Hospital Stroke Program between July 2000 and December 2002. Self-reported risk factors for stroke were obtained on admission. Stroke severity was determined by the admission National Institutes of Health Stroke Scale score. Good outcome was defined as a Rankin score < 2 at discharge. Statistical analyses used univariate and multivariate logistic regression models. Results: There were 436 patients with a final diagnosis of ischemic stroke; statin data were available for 433 of them. A total of 95/433 (22%) of patients were taking a statin when they were admitted, rising from 16% in 2000 to 26% in 2002. Fifty-one percent of patients taking statins had a good outcome compared to 38% of patients not taking statins (p = 0.03). After adjustment for confounding factors, statin pretreatment was associated with a 2.9 odds (95% CI: 1.2-6.7) of a good outcome at the time of hospital discharge. Conclusions: The proportion of patients taking statins when they are admitted with stroke is rising rapidly. Statin pretreatment was significantly associated with an improved functional outcome at discharge. This finding could support the early initiation of statin therapy after stroke.

AB - Background: Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) have neuroprotective effects in experimental stroke models and are commonly prescribed in clinical practice. The aim of this study was to determine if patients taking statins before hospital admission for stroke had an improved clinical outcome. Methods: This was an observational study of 436 patients admitted to the National Institutes of Health Suburban Hospital Stroke Program between July 2000 and December 2002. Self-reported risk factors for stroke were obtained on admission. Stroke severity was determined by the admission National Institutes of Health Stroke Scale score. Good outcome was defined as a Rankin score < 2 at discharge. Statistical analyses used univariate and multivariate logistic regression models. Results: There were 436 patients with a final diagnosis of ischemic stroke; statin data were available for 433 of them. A total of 95/433 (22%) of patients were taking a statin when they were admitted, rising from 16% in 2000 to 26% in 2002. Fifty-one percent of patients taking statins had a good outcome compared to 38% of patients not taking statins (p = 0.03). After adjustment for confounding factors, statin pretreatment was associated with a 2.9 odds (95% CI: 1.2-6.7) of a good outcome at the time of hospital discharge. Conclusions: The proportion of patients taking statins when they are admitted with stroke is rising rapidly. Statin pretreatment was significantly associated with an improved functional outcome at discharge. This finding could support the early initiation of statin therapy after stroke.

UR - http://www.scopus.com/inward/record.url?scp=3242713612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3242713612&partnerID=8YFLogxK

U2 - 10.1186/1741-7015-2-4

DO - 10.1186/1741-7015-2-4

M3 - Article

C2 - 15035663

AN - SCOPUS:3242713612

VL - 2

JO - BMC Medicine

JF - BMC Medicine

SN - 1741-7015

M1 - 4

ER -